Owners, management and financials
CVR: 25630483
Previous names: HB-MEDICAL ApS, HB MEDICAL HØRSHOLM APS, Nord Pharma Partners ApS
DKK 61,605
Gross profit
Net result: DKK 139,819
XGX Pharma ApS (100%)
CVR · view owners
Jens-Nikolaj Schøier
CVR · view management
Active
Founded 20 September 2000
CVR · view overview
2 employees
CVR · 2021
Name registered: Frederiksstaden Pharma ApS
CVR · 05/05/2022
View the full event history
Frederiksstaden Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2000. The company is registered under the industry Pakkeriaktiviteter. The company was previously named NPPHorsholm ApS and Nord Pharma Partners ApS. The management consists of Jens-Nikolaj Schøier. The company is owned by XGX Pharma ApS. The company has 2 employees (2021). In 2025, the company reported a gross profit of DKK 61,605 and a net result of DKK 139,819 compared with DKK -50,518 the year before. Equity in the 2025 report amounted to DKK 237,986.
Selskabets formål er at drive virksomhed, som udfører kontrakt-/lønarbejde for biotekvirksomheder, lægemiddelproducenter og andre med behov for sterile/partikelfri flydende produkter, samt farmaceutisk konsulentvirksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 62K | 140K | 864K | 238K | 0 | |
| 202401/01/2024 – 31/12/2024 | -39K | -51K | 407K | 98K | 0 | |
| 202301/01/2023 – 31/12/2023 | -80K | -82K | 328K | 149K | 0 | |
| 202201/01/2022 – 31/12/2022 | 13K | 4K | 264K | 231K | 0 | |
| 202101/01/2021 – 31/12/2021 | -666K | -1.4M | 737K | 227K | 3 | |
| 202001/01/2020 – 31/12/2020 | 2M | -1.8M | 5.3M | 1.6M | 7 | |
| 201901/05/2018 – 30/04/2019 | 1.4M | -3.3M | 2.4M | -2.2M | - | |
| 201801/05/2017 – 30/04/2018 | 2.2M | -6.2M | 2.3M | 1.1M | - | |
| 201701/05/2016 – 30/04/2017 | 5.6M | -2.4M | 10.2M | 7.3M | - | |
| 201401/01/2014 – 31/12/2014 | 3.5M | -286K | 2.3M | -2.2M | 14 | |
| 201301/01/2013 – 31/12/2013 | 3.8M | -2.3M | 2.5M | -1.9M | 14 | |
| 201201/01/2012 – 31/12/2012 | 6.7M | 40K | 2.8M | 426K | 19 |
Compared to 54 companies in Pakkeriaktiviteter
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of Frederiksstaden Pharma ApS is 25630483.
Frederiksstaden Pharma ApS is owned by XGX Pharma ApS.
The management of Frederiksstaden Pharma ApS consists of Jens-Nikolaj Schøier.
In 2025, Frederiksstaden Pharma ApS reported a gross profit of DKK 61,605.
Frederiksstaden Pharma ApS had 2 employees in 2021 according to the Danish CVR register.
Frederiksstaden Pharma ApS was founded on 20 September 2000.
Claim this page to add your logo and social links. Free to get started.
Frederiksstaden Pharma ApS has published its annual report for 2025. Gross profit came to DKK 61,605, and the net result was DKK 139,819.
As of July 21, 2025, KPMG P/S has been appointed auditor of Frederiksstaden Pharma ApS.
As of July 21, 2025, Kreston CM Statsautoriseret Revisions interessentskab has stepped down as auditor of Frederiksstaden Pharma ApS.
Frederiksstaden Pharma ApS has published its annual report for 2024. Gross profit came to DKK -39,059, and the net result was DKK -50,518.
Frederiksstaden Pharma ApS has published its annual report for 2023. Gross profit came to DKK -79,848, and the net result was DKK -82,296.
Frederiksstaden Pharma ApS has published its annual report for 2022. Gross profit came to DKK 13,098, and the net result was DKK 3,759.
As of May 5, 2022, Mohammad Sohail Asghar has left the board of directors of Frederiksstaden Pharma ApS.
As of May 5, 2022, Søren Wang Petersen has left the board of directors of Frederiksstaden Pharma ApS.
As of May 5, 2022, Rolf Eckersberg has left the board of directors of Frederiksstaden Pharma ApS.
As of May 5, 2022, Jens-Nikolaj Schøier has left the board of directors of Frederiksstaden Pharma ApS.
As of May 5, 2022, Jens-Nikolaj Schøier is registered as director of Frederiksstaden Pharma ApS.
As of May 5, 2022, Rolf Eckersberg has stepped down as director of Frederiksstaden Pharma ApS.
On May 5, 2022, the company changed its name from NPPHorsholm ApS to Frederiksstaden Pharma ApS.
As of April 27, 2022, XGX Pharma ApS is registered as an owner of Frederiksstaden Pharma ApS with an ownership share of 100%.
Frederiksstaden Pharma ApS has published its annual report for 2021. Gross profit came to DKK -666,382, and the net result was DKK -1,410,402.
On September 24, 2021, the company changed its name from Nord Pharma Partners ApS to NPPHorsholm ApS.
As of June 29, 2021, Rolf Eckersberg has joined the board of directors of Frederiksstaden Pharma ApS.
As of June 29, 2021, Susanne Ølsgaard Felumb has left the board of directors of Frederiksstaden Pharma ApS.
As of June 29, 2021, Rolf Eckersberg is registered as director of Frederiksstaden Pharma ApS.
As of June 29, 2021, Susanne Ølsgaard Felumb has stepped down as director of Frederiksstaden Pharma ApS.
Frederiksstaden Pharma ApS has published its annual report for 2020. Gross profit came to DKK 2,043,715, and the net result was DKK -1,773,020.
As of February 15, 2021, Susanne Ølsgaard Felumb is registered as director of Frederiksstaden Pharma ApS.
As of February 15, 2021, Klaus Snej Jensen has stepped down as director of Frederiksstaden Pharma ApS.
As of May 1, 2020, Susanne Ølsgaard Felumb has joined the board of directors of Frederiksstaden Pharma ApS.
On May 1, 2020, the company changed its name from HB MEDICAL HØRSHOLM APS to Nord Pharma Partners ApS.
Frederiksstaden Pharma ApS has published its interim report for the period May 1, 2019 to December 31, 2019.
As of February 7, 2020, Kreston CM Statsautoriseret Revisions interessentskab has been appointed auditor of Frederiksstaden Pharma ApS.
As of February 7, 2020, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Frederiksstaden Pharma ApS.
As of February 1, 2020, Klaus Snej Jensen is registered as director of Frederiksstaden Pharma ApS.
As of February 1, 2020, Jens-Nikolaj Schøier has stepped down as director of Frederiksstaden Pharma ApS.
As of December 27, 2019, Søren Wang Petersen has joined the board of directors of Frederiksstaden Pharma ApS.
As of December 19, 2019, Jens-Nikolaj Schøier has joined the board of directors of Frederiksstaden Pharma ApS.
As of December 19, 2019, Per Ludvigsen has left the board of directors of Frederiksstaden Pharma ApS.
As of December 18, 2019, Jens-Nikolaj Schøier has left the board of directors of Frederiksstaden Pharma ApS.
As of December 2, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Frederiksstaden Pharma ApS.
As of December 2, 2019, 18. juni 2024 P/S has stepped down as auditor of Frederiksstaden Pharma ApS.
As of December 2, 2019, Mohammad Sohail Asghar has joined the board of directors of Frederiksstaden Pharma ApS.
As of December 2, 2019, Per Ludvigsen has joined the board of directors of Frederiksstaden Pharma ApS.
As of December 2, 2019, Jens-Nikolaj Schøier has joined the board of directors of Frederiksstaden Pharma ApS.
As of December 2, 2019, Henrik Grundtvig has left the board of directors of Frederiksstaden Pharma ApS.
As of December 2, 2019, Michael Grundtvig has left the board of directors of Frederiksstaden Pharma ApS.
As of December 2, 2019, Lars Karlsmose has left the board of directors of Frederiksstaden Pharma ApS.
As of December 2, 2019, Jens-Nikolaj Schøier is registered as director of Frederiksstaden Pharma ApS.
As of December 2, 2019, Lars Karlsmose has stepped down as director of Frederiksstaden Pharma ApS.
As of August 9, 2019, Henrik Grundtvig has joined the board of directors of Frederiksstaden Pharma ApS.
As of August 9, 2019, Lars Karlsmose has joined the board of directors of Frederiksstaden Pharma ApS.
As of August 9, 2019, Lars Karlsmose is registered as director of Frederiksstaden Pharma ApS.
As of August 9, 2019, Hans Flemming Haagen Jensen has stepped down as adm. dir. of Frederiksstaden Pharma ApS.
As of August 8, 2019, Henrik Grundtvig has left the board of directors of Frederiksstaden Pharma ApS.
As of August 8, 2019, Lars Karlsmose has left the board of directors of Frederiksstaden Pharma ApS.
Frederiksstaden Pharma ApS has published its annual report for 2019. Gross profit came to DKK 1,352,134, and the net result was DKK -3,296,605.
As of June 25, 2019, Henrik Grundtvig has joined the board of directors of Frederiksstaden Pharma ApS.
As of June 25, 2019, Michael Grundtvig has joined the board of directors of Frederiksstaden Pharma ApS.
As of June 25, 2019, Hans Flemming Haagen Jensen has left the board of directors of Frederiksstaden Pharma ApS.
As of June 25, 2019, Helle Bøwadt has left the board of directors of Frederiksstaden Pharma ApS.
As of January 15, 2019, Lars Grundtvig has left the board of directors of Frederiksstaden Pharma ApS.
Frederiksstaden Pharma ApS has published its annual report for 2018. Gross profit came to DKK 2,163,299, and the net result was DKK -6,239,627.
As of September 20, 2018, Lars Grundtvig has joined the board of directors of Frederiksstaden Pharma ApS.
As of September 20, 2018, Lars Karlsmose has joined the board of directors of Frederiksstaden Pharma ApS.
As of September 19, 2018, Lars Grundtvig has left the board of directors of Frederiksstaden Pharma ApS.
Frederiksstaden Pharma ApS has published its annual report for 2017. Gross profit came to DKK 5,638,880, and the net result was DKK -2,380,145.
As of October 6, 2016, Hans Flemming Haagen Jensen has joined the board of directors of Frederiksstaden Pharma ApS.
As of October 6, 2016, Helle Bøwadt has joined the board of directors of Frederiksstaden Pharma ApS.
As of October 6, 2016, Hans Flemming Haagen Jensen is registered as adm. dir. of Frederiksstaden Pharma ApS.
As of October 6, 2016, Helle Bøwadt has stepped down as director of Frederiksstaden Pharma ApS.
As of October 5, 2016, Hans Flemming Haagen Jensen has left the board of directors of Frederiksstaden Pharma ApS.
As of October 5, 2016, Helle Bøwadt has left the board of directors of Frederiksstaden Pharma ApS.
Frederiksstaden Pharma ApS has published its interim report for the period October 1, 2015 to April 30, 2016.
As of April 26, 2016, Lars Grundtvig has joined the board of directors of Frederiksstaden Pharma ApS.
As of April 26, 2016, Hans Flemming Haagen Jensen has joined the board of directors of Frederiksstaden Pharma ApS.
As of April 26, 2016, Helle Bøwadt has joined the board of directors of Frederiksstaden Pharma ApS.
On April 26, 2016, the company changed its name from HB-MEDICAL ApS to HB MEDICAL HØRSHOLM APS.
Frederiksstaden Pharma ApS has published its interim report for the period January 1, 2015 to September 30, 2015.
As of September 25, 2015, 18. juni 2024 P/S has been appointed auditor of Frederiksstaden Pharma ApS.
As of September 25, 2015, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Frederiksstaden Pharma ApS.
Frederiksstaden Pharma ApS has published its annual report for 2014. Gross profit came to DKK 3,543,681, and the net result was DKK -286,274.
Frederiksstaden Pharma ApS has published its annual report for 2013. Gross profit came to DKK 3,824,708, and the net result was DKK -2,327,082.
Frederiksstaden Pharma ApS has published its annual report for 2012. Gross profit came to DKK 6,659,175, and the net result was DKK 40,170.
As of October 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Frederiksstaden Pharma ApS.
As of October 13, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of Frederiksstaden Pharma ApS.
As of September 20, 2000, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of Frederiksstaden Pharma ApS.
As of September 20, 2000, Helle Bøwadt is registered as director of Frederiksstaden Pharma ApS.
Frederiksstaden Pharma ApS was founded on September 20, 2000.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 44140721
CVR 21231894
CVR 43888684
CVR 30937198
CVR 42434361
